首页|期刊导航|癌症生物学与医学（英文版）|Efficacy and safety of first-line osimertinib in Chinese patients with EGFR-mutated advanced non-small cell lung cancer:a prospective,multicenter,non-interventional study(FLOURISH)

Efficacy and safety of first-line osimertinib in Chinese patients with EGFR-mutated advanced non-small cell lung cancer:a prospective,multicenter,non-interventional study(FLOURISH)

Lisha Shen Ligang Xing Ke Xie Jiuwei Cui Lin Mu Chao Cao Liren Ding Peifeng Chen Jun Liang Yongmin Ding Liqin Lu Dongqing Lv Jiliang Zhang Xinmin Yu Li Chen Jing Zheng Jianya Zhou Jianying Zhou Ke-Jing Tang Jun Zhao Dan Zhu Yanqiu Zhao Ke Wang Yan Wang Zhigang Cai

癌症生物学与医学（英文版）2026，Vol.23Issue(8)：1156-1166,中插7-中插10,15.

癌症生物学与医学（英文版）2026，Vol.23Issue(8)：1156-1166,中插7-中插10,15.DOI:10.20892/j.issn.2095-3941.2025.0566

Efficacy and safety of first-line osimertinib in Chinese patients with EGFR-mutated advanced non-small cell lung cancer:a prospective,multicenter,non-interventional study(FLOURISH)

Lisha Shen ¹Ligang Xing ²Ke Xie ³Jiuwei Cui ⁴Lin Mu ⁵Chao Cao ⁶Liren Ding ⁷Peifeng Chen ⁸Jun Liang ⁹Yongmin Ding ¹⁰Liqin Lu ¹¹Dongqing Lv ¹²Jiliang Zhang ¹³Xinmin Yu ¹⁴Li Chen ¹⁵Jing Zheng ¹Jianya Zhou ¹Jianying Zhou ¹Ke-Jing Tang ¹⁶Jun Zhao ¹⁷Dan Zhu ¹⁸Yanqiu Zhao ¹⁹Ke Wang ²⁰Yan Wang ²¹Zhigang Cai²²

作者信息

1. Department of Respiratory Disease,Thoracic Disease Center,The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310058,China
2. Shandong Cancer Hospital and Institute,Shandong First Medical University,Jinan 250014,China
3. Sichuan Provincial People's Hospital,Chengdu 610072,China
4. The First Hospital of Jilin University,Changchun 130021,China
5. Heping Hospital Affiliated to Changzhi Medical College,Changzhi 046000,China
6. The First Affiliated Hospital of Ningbo University,Ningbo 315010,China
7. The Second Affiliated Hospital(Binjiang Campus),School of Medicine,Zhejiang University,Hangzhou 310022,China
8. Zhuji People's Hospital,Zhuji 311800,China
9. Peking University International Hospital,Beijing 102206,China
10. Shengzhou People's Hospital,Shengzhou 312400,China
11. Zhejiang Provincial People's Hospital,Hangzhou 310014,China
12. Department of Respiratory Disease,Affiliated Taizhou Hospital of Zhejiang Province of Wenzhou Medical University,Taizhou 318000,China
13. Chengdu Seventh People's Hospital(Affiliated Cancer Hospital of Chengdu Medical College),Chengdu 610072,China
14. Zhejiang Cancer Hospital,Hangzhou 310022,China
15. The First Affiliated Hospital of Nanchang University,Nanchang 330006,China
16. Department of Respiratory Disease,The First Affiliated Hospital of Sun Yat-sen University,Guangzhou 510080,China
17. Changzhi People's Hospital Affiliated to Changzhi Medical College,Changzhi 046000,China
18. Jinhua Municipal Central Hospital,Jinhua 321000,China
19. The Affiliated Cancer Hospital of Zhengzhou University&Henan Cancer Hospital,Zhengzhou 450008,China
20. West China Hospital of Sichuan University,Chengdu 610041,China
21. Tumor Hospital Affiliated to Harbin Medical University,Harbin 150081,China
22. The Second Hospital of Hebei Medical University,Shijiazhuang 050000,China
折叠

摘要

关键词

Osimertinib/epidermal growth factor receptor/non-small cell lung cancer/real-world/co-mutations

Key words

Osimertinib/epidermal growth factor receptor/non-small cell lung cancer/real-world/co-mutations

引用本文复制引用

Lisha Shen,Ligang Xing,Ke Xie,Jiuwei Cui,Lin Mu,Chao Cao,Liren Ding,Peifeng Chen,Jun Liang,Yongmin Ding,Liqin Lu,Dongqing Lv,Jiliang Zhang,Xinmin Yu,Li Chen,Jing Zheng,Jianya Zhou,Jianying Zhou,Ke-Jing Tang,Jun Zhao,Dan Zhu,Yanqiu Zhao,Ke Wang,Yan Wang,Zhigang Cai..Efficacy and safety of first-line osimertinib in Chinese patients with EGFR-mutated advanced non-small cell lung cancer:a prospective,multicenter,non-interventional study(FLOURISH)[J].癌症生物学与医学（英文版）,2026,23(8):1156-1166,中插7-中插10,15.

基金项目

This work was supported by a grant from AstraZeneca China. （）

癌症生物学与医学（英文版）

ISSN：2095-3941

访问量0

下载量0

段落导航